February 2026 Highlights from the Health & Clinical and Life Sciences Research Communities: Rare Disease Day
Published in Cell & Molecular Biology, Biomedical Research, and General & Internal Medicine
Rare Disease Day 2026 reminds us that while each rare condition may affect a small number of people, together they impact 300 million people worldwide. Across the Research Communities this month, authors have shared powerful stories, research insights, and reflections such as policy alignment, patient advocacy and lived experiences of diagnosis.
Here, we highlight five standout posts that explore the realities of rare disease research and care, and the people working to drive change.
Zainab Alani‘s story of Myasthenia: more than muscle weakness

In this deeply personal Life in Research post for Rare Disease Day 2026, @Zainab Alani, Medical Student at the University of Glasgow, shares her journey of living with generalised Myasthenia Gravis - a rare, incurable autoimmune condition that reshaped her daily life, medical training, and sense of identity. Zainab shares how she navigated diagnosis and relapse and became a national advocate featured on BBC Scotland. She reflects on the realities of chronic illness, the strength of family support, and her mission to empower other young people through initiatives like Rarely Social.
Read the full post for an honest, uplifting account of life beyond a rare diagnosis, and a powerful reminder that rare does not mean invisible.
Uniting for Rare Diseases
Progress in rare disease research depends not only on discovery, but on coordination. In this Behind the Paper post, @María Sánchez, Researcher at the Institute for Rare Diseases Research, reflects on her team’s article published in Health Research Policy and Systems. Drawing on five years of work within the European Joint Programme on Rare Diseases, the paper examines how better alignment between national strategies, funding, and research priorities can accelerate progress for the 300 million people affected worldwide. From mapping unmet needs to establishing National Mirror Groups, the post reveals the collaborative effort behind building a more connected rare disease ecosystem.
Read the full post to explore why alignment across countries, policies, and stakeholders is essential to delivering more equitable diagnosis, care, and innovation.

Navigating Lupus, race and the struggle for health equity
Lupus is more than a medical condition. It is shaped by race, gender, bias, and the systems meant to provide care. In this powerful News & Opinion piece, @India Sapsed-Foster shares the story of Madonna Grant, who reflects on delayed diagnosis, systemic inequities, and the lived reality of navigating lupus as a Black woman. Through candid discussion of bias within the NHS, gaps in clinical research, and the disproportionate impact of lupus on Black women, the post highlights why inclusive research, culturally competent care, and action on the Sustainable Development Goals are essential to achieving true health equity.
Read the full post for a deeply human perspective on chronic illness, and a call to ensure that equity in healthcare is more than an aspiration.

An update from the 2023 Student Voice Prize
Rare diseases are often defined by uncertainty in diagnosis, in treatment decisions, and in daily life. In this Rare Disease Day 2026 update, @Iman Muzafar reflects on their experience as runner-up in the Student Voice Prize and her ongoing collaboration with Cavernoma Alliance UK. The post revisits their original piece, Endless Uncertainty: Living with a rare condition, and explores the realities of cavernomas, rare vascular malformations affecting the brain and spinal cord, alongside the complex decisions patients face. Iman highlights how patient advocacy groups help drive research, improve information, and provide vital peer support.
Read the full post to discover how lived experience, research, and advocacy continue to shape progress for people navigating rare neurological conditions.

How is Springer Nature highlighting Rare Disease Day?
Although each rare disease affects a small number of people, together they impact millions worldwide, making awareness, research, and collaboration more important than ever. In this Rare Disease Day 2026 roundup, @Sanja Evenson and @William Shadbolt spotlight selected content from Springer Nature journals including Orphanet Journal of Rare Diseases, Scientific Reports, and Human Genome Variation. The post highlights new calls for papers, advances in AI-supported diagnostics, clinical research updates, and initiatives aimed at improving care and coordination worldwide.
Read the full post to explore the latest research and discover how you can get involved.
February’s round-up focusing on Rare Disease Day shows that progress in rare diseases depends on visibility, inclusion, and collective action. Whether through research, advocacy, or storytelling, every contribution helps move us closer to earlier diagnoses, fairer access to care, and stronger global alignment. Explore the full posts to learn more and share your thoughts in the comments.
Further reading:
- Top Posts from the Research Communities in 2025: A Year in Review
- February Highlights from Mathematics, Physical and Applied Sciences Communities
-
January Highlights from Medicine and Life Sciences Research Communities
Follow the Topic
-
Scientific Reports
An open access journal publishing original research from across all areas of the natural sciences, psychology, medicine and engineering.
-
Orphanet Journal of Rare Diseases
An open access, peer-reviewed journal that encompasses all aspects of rare diseases and orphan drugs and publishes high-quality reviews on specific rare diseases.
-
Health Research Policy and Systems
This journal covers all aspects of the organisation and use of health research – including agenda setting, building health research capacity, and how research as a whole benefits decision makers, practitioners in health and related fields, and society at large.
-
Human Genome Variation
This is an online-only, full open access journal that contains articles and reports about variation and variability in human genomes and the consequences, implications and future impacts for the study of human genomics.
Your space to connect: The Primary immunodeficiency disorders Hub
A new Communities’ space to connect, collaborate, and explore research on Clinical Medicine, Immunology, and Diseases!
Continue reading announcementRelated Collections
With Collections, you can get published faster and increase your visibility.
The Emerging Frontiers of Genetic Screening in Inherited Disorders
The core challenge of modern preventive medicine is the accurate and timely identification of individuals at risk for genetic disorders. For decades, genetic testing has been gated by restrictive clinical criteria and "phenotype-first" models, which often rely on family history or specific symptoms to trigger a diagnostic workup. However, emerging evidence highlights a significant diagnostic gap: a substantial proportion of individuals carrying clinically actionable pathogenic variants are currently missed because they do not meet traditional testing guidelines or lack a documented family history of disease.
This Collection focuses on how the next generation of screening technologies can expand diagnostic capacity and maximize diagnostic yield. We are moving toward a "genome-first" era, in which criteria-independent testing and the integration of multimodal data enable the identification of individuals at risk who were previously undetected within the healthcare system. By leveraging advanced sequencing technologies and computational infrastructures, we can shift from reactive diagnostics to proactive, large-scale screening strategies that improve clinical outcomes across multiple medical disciplines.
Key Areas of Interest
We invite original research, reviews, and clinical perspectives that explore the technological and clinical pathways to increasing diagnostic sensitivity and specificity:
- Expanding the Diagnostic Net: Evaluating the clinical utility of criteria-independent or universal screening to identify high-risk individuals who would otherwise remain undetected under standard guidelines.
- Genome-First Implementation: Analysing the impact of population-based genomic screening in uncovering hereditary diseases or pathogenic variants associated with inherited diseases before the onset of clinical symptoms.
- Synergistic Diagnostic Modalities: The integration of DNA sequencing with other high-resolution markers, such as biochemical profiling or functional assays, to refine risk assessment and increase diagnostic precision.
- Opportunistic Screening and Secondary Findings: Best practices for managing and reporting actionable genetic findings discovered during routine clinical sequencing.
- Scalable Screening Architectures: Innovative approaches to integrating large-scale genetic data into healthcare systems, including the use of electronic health records to support automated risk identification.
- Overcoming Implementation Barriers: Strategies to mitigate disparities in access to screening, focusing on populations in which reliable family history information is limited.
All submissions in this Collection undergo the journal’s standard peer review process. Similarly, all manuscripts authored by a Guest Editor(s) will be handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.
Publishing Model: Open Access
Deadline: Jan 16, 2027
Approaches for identifying pathogenic variants causing rare diseases
Publishing Model: Open Access
Deadline: Jul 16, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in